Immunome
IMNM
#6606
Rank
A$0.85 B
Marketcap
$9.81
Share price
-4.97%
Change (1 day)
-68.11%
Change (1 year)

Immunome (IMNM) - Cash on Hand

Cash on Hand as of December 2024 : A$0.35 Billion

According to Immunome's latest financial reports the company has A$0.35 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Immunome - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.34 B72.3%
2023-12-31A$0.20 B578.94%
2022-12-31A$29.86 M-56.02%
2021-12-31A$67.9 M31.3%
2020-12-31A$51.71 M1323.85%
2019-12-31A$3.63 M59.72%
2018-12-31A$2.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.42 B 17.79%๐Ÿ‡บ๐Ÿ‡ธ USA